These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1681947)
1. Decreased serum dipeptidyl peptidase IV activity in major depression. Maes M; De Meester I; Vanhoof G; Scharpé S; Bosmans E; Vandervorst C; Verkerk R; Minner B; Suy E; Raus J Biol Psychiatry; 1991 Sep; 30(6):577-86. PubMed ID: 1681947 [TBL] [Abstract][Full Text] [Related]
2. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Maes M; Bosmans E; Suy E; Vandervorst C; DeJonckheere C; Raus J Acta Psychiatr Scand; 1991 Oct; 84(4):379-86. PubMed ID: 1746291 [TBL] [Abstract][Full Text] [Related]
3. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. Maes M; De Meester I; Verkerk R; De Medts P; Wauters A; Vanhoof G; Vandoolaeghe E; Neels H; Scharpé S Psychoneuroendocrinology; 1997 Feb; 22(2):65-78. PubMed ID: 9149329 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Maes M; Lambrechts J; Bosmans E; Jacobs J; Suy E; Vandervorst C; de Jonckheere C; Minner B; Raus J Psychol Med; 1992 Feb; 22(1):45-53. PubMed ID: 1574566 [TBL] [Abstract][Full Text] [Related]
5. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323 [TBL] [Abstract][Full Text] [Related]
6. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Maes M; Meltzer HY; Scharpé S; Bosmans E; Suy E; De Meester I; Calabrese J; Cosyns P Psychiatry Res; 1993 Nov; 49(2):151-65. PubMed ID: 7908745 [TBL] [Abstract][Full Text] [Related]
7. T-cell immune parameters and depression in patients with Crohn's disease. Rose M; Hildebrandt M; Fliege H; Seibold S; Mönnikes H; Klapp BF J Clin Gastroenterol; 2002 Jan; 34(1):40-8. PubMed ID: 11743244 [TBL] [Abstract][Full Text] [Related]
8. The activity of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice immunized with type II collagen. Fujita K; Hagihara M; Nagatsu T; Iwata H; Miura T Biochem Med Metab Biol; 1992 Dec; 48(3):227-34. PubMed ID: 1362072 [TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Stancíková M; Lojda Z; Lukác J; Ruzicková M Clin Exp Rheumatol; 1992; 10(4):381-5. PubMed ID: 1356680 [TBL] [Abstract][Full Text] [Related]
10. Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen. Gruber M; Scholz W; Flad HD Cell Immunol; 1988 May; 113(2):423-34. PubMed ID: 2896071 [TBL] [Abstract][Full Text] [Related]
11. Serum postdexamethasone prolactin measures in depressive patients and control subjects. Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707 [TBL] [Abstract][Full Text] [Related]
12. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Ulmer AJ; Mattern T; Feller AC; Heymann E; Flad HD Scand J Immunol; 1990 Apr; 31(4):429-35. PubMed ID: 1970666 [TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747 [TBL] [Abstract][Full Text] [Related]
14. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Maes M; Capuron L; Ravaud A; Gualde N; Bosmans E; Egyed B; Dantzer R; Neveu PJ Neuropsychopharmacology; 2001 Feb; 24(2):130-40. PubMed ID: 11120395 [TBL] [Abstract][Full Text] [Related]
15. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Scharpé S; De Meester I; Vanhoof G; Hendriks D; van Sande M; Van Camp K; Yaron A Clin Chem; 1988 Nov; 34(11):2299-301. PubMed ID: 2902942 [TBL] [Abstract][Full Text] [Related]
16. Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects. Maes M; Scharpé S; De Meester I; Goossens P; Wauters A; Neels H; Verkerk R; De Meyer F; D'Hondt P; Peeters D Clin Chem; 1994 Sep; 40(9):1686-91. PubMed ID: 7915215 [TBL] [Abstract][Full Text] [Related]
17. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Maes M; Bosmans E; Suy E; Vandervorst C; De Jonckheere C; Raus J Neuropsychobiology; 1990-1991; 24(3):115-20. PubMed ID: 2135065 [TBL] [Abstract][Full Text] [Related]
18. Presence of dipeptidyl peptidase II, dipeptidyl peptidase IV, and prolyl endopeptidase in effusion from patients with serous otitis media. Rao AJ; Hagihara M; Nagatsu T; Yanagita N Biochem Med Metab Biol; 1990 Jun; 43(3):276-82. PubMed ID: 1974452 [TBL] [Abstract][Full Text] [Related]